Stock CLSR.B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Clinical Laserthermia Systems AB Swiss Exchange

Equities

CLSR.B

SE0002756130

End-of-day quote Swiss Exchange
Other stock markets
- SEK - Intraday chart for Clinical Laserthermia Systems AB
05-31 Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue MT
05-29 Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CLS publishes prospectus in connection with forthcoming rights issue
AQ
Clinical Laserthermia Systems publishes annual report for 2023
AQ
BioStock: CLS' partner initiates full market release in the US
AQ
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
AQ
CLS presents its new strategic direction in a Business Update Event on June 12
AQ
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
AQ
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
AQ
CLS publishes interim report January - March 2024
AQ
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024
AQ
BioStock: CLS revises strategy - increases focus on neurosurgery
AQ
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
AQ
BioStock: CLS launches in France
AQ
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
AQ
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
AQ
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
AQ
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
AQ
BioStock: CLS makes progress in prostate cancer in Europe and the US
AQ
Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system
AQ
CLS receives second order from the National Institutes of Health Clinical Center in the US
AQ
As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. CLSR.B Stock
  5. News Clinical Laserthermia Systems AB
  6. Press Releases